THE RESULTS OF THE SIPPET STUDY

An international, randomized clinical trial to study inhibitor development in patients with severe hemophilia A previously untreated (PUPs) or minimally exposed to blood components when treated with plasma-derived FVIII containing von Willebrand Factor or treated with recombinant products.
This study has just been published in The New England Journal of Medicine.

» SIPPET Study Questions & Answers